Cardinal Health, Inc. (LON:0HTG)
212.66
-1.77 (-0.82%)
At close: Nov 28, 2025
Cardinal Health Revenue
Cardinal Health had revenue of $64.01B USD in the quarter ending September 30, 2025, with 22.44% growth. This brings the company's revenue in the last twelve months to $262.47B, up 2.07% year-over-year. In the fiscal year ending June 30, 2025, Cardinal Health had annual revenue of $222.58B, down -1.87%.
Revenue (ttm)
$262.47B
Revenue Growth
+2.07%
P/S Ratio
0.22
Revenue / Employee
$4.55M
Employees
57,700
Market Cap
38.10B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 222.58B | -4.25B | -1.87% |
| Dec 31, 2024 | 226.83B | - | - |
| Jun 30, 2024 | 226.83B | 21.85B | 10.66% |
| Dec 31, 2023 | 204.98B | - | - |
| Jun 30, 2023 | 204.98B | 23.65B | 13.04% |
| Dec 31, 2022 | 181.33B | -38.00M | -0.02% |
| Jun 30, 2022 | 181.36B | 18.90B | 11.63% |
| Jun 30, 2021 | 162.47B | 9.55B | 6.24% |
| Dec 31, 2020 | 152.92B | - | - |
| Jun 30, 2020 | 152.92B | 7.39B | 5.08% |
| Dec 31, 2019 | 145.53B | - | - |
| Jun 30, 2019 | 145.53B | 8.73B | 6.38% |
| Dec 31, 2018 | 136.81B | - | - |
| Jun 30, 2018 | 136.81B | 6.83B | 5.26% |
| Jun 30, 2017 | 129.98B | 8.43B | 6.94% |
| Jun 30, 2016 | 121.55B | 19.02B | 18.55% |
| Jun 30, 2015 | 102.53B | 11.45B | 12.57% |
| Jun 30, 2014 | 91.08B | -10.01B | -9.90% |
| Jun 30, 2013 | 101.09B | -6.46B | -6.01% |
| Jun 30, 2012 | 107.55B | 4.91B | 4.78% |
| Jun 30, 2011 | 102.64B | 4.14B | 4.20% |
| Jun 30, 2010 | 98.50B | 2.51B | 2.62% |
| Jun 30, 2009 | 95.99B | 8.58B | 9.82% |
| Jun 30, 2008 | 87.41B | 653.20M | 0.75% |
| Jun 30, 2007 | 86.76B | 7.09B | 8.90% |
| Jun 30, 2006 | 79.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Cardinal Health News
- 10 hours ago - Best Dividend Aristocrats For December 2025 - Seeking Alpha
- 5 days ago - Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes" - Nasdaq
- 5 days ago - Cardinal (CAH) Upgraded to Buy: Here's Why - Nasdaq
- 8 days ago - Here's Why Cardinal Health (CAH) is a Strong Momentum Stock - Nasdaq
- 10 days ago - Stop Sleeping on These 3 Stocks (Seriously) - The Motley Fool
- 11 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 11 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 15 days ago - Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today - Benzinga